Valuation: Ibnsina Pharma

Market Cap 10.68B 198M 177M 164M 149M 279M 18.79B 284M 1.96B 772M 9.82B 744M 728M 31.4B P/E 2026 *
9.38x
P/E 2027 * 7.18x
Enterprise Value 19.31B 358M 319M 296M 269M 505M 33.97B 513M 3.55B 1.4B 17.75B 1.34B 1.32B 56.76B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.17x
Free-Float
58.26%
Yield 2026 *
2.74%
Yield 2027 * 3.87%
1 week-5.86%
Current month-7.83%
1 month-12.83%
3 months-7.67%
6 months-1.49%
Current year-9.56%
1 week 10.3
Extreme 10.3
11.3
1 month 10.03
Extreme 10.03
12.26
Current year 9.63
Extreme 9.63
16.93
1 year 9.63
Extreme 9.63
16.93
3 years 2.08
Extreme 2.08
16.93
5 years 1.1
Extreme 1.101
16.93
10 years 1.1
Extreme 1.101
16.93
Manager TitleAgeSince
Chief Executive Officer - 18/12/2000
Chief Executive Officer - 18/12/2000
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 18/12/2000
Director/Board Member - 18/12/2000
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-5.86%-6.85%+406.69% 200M
+1.40%+7.56%-38.31%+10.37% 15.67B
+16.29%-0.56%+11.17%-17.55% 7.07B
+0.56%+5.65%-12.04%+6.13% 6.34B
+0.99%+4.78%-10.68%+1.07% 6.34B
0.00%+6.14%-49.83%-32.78% 6.19B
+1.16%+1.52%+2.71%-6.12% 4.54B
+0.74%+12.56%-33.86%-0.05% 3.41B
+0.43%+3.71%-13.49%-9.06% 3.24B
+2.47%-0.68%+8.97%-17.94% 3.17B
Average +2.43%+1.58%-14.22%+34.08% 5.62B
Weighted average by Cap. +2.89%+3.00%-19.47%-2.70%

Financials

2026 *2027 *
Net sales 94.39B 1.75B 1.56B 1.45B 1.31B 2.47B 166B 2.51B 17.34B 6.82B 86.77B 6.57B 6.43B 277B 103B 1.91B 1.7B 1.57B 1.43B 2.69B 181B 2.73B 18.88B 7.43B 94.48B 7.15B 7B 302B
Net income 1.18B 21.95M 19.56M 18.12M 16.48M 30.92M 2.08B 31.43M 217M 85.47M 1.09B 82.34M 80.61M 3.48B 1.58B 29.36M 26.17M 24.24M 22.04M 41.36M 2.78B 42.04M 291M 114M 1.45B 110M 108M 4.65B
Net Debt 8.63B 160M 143M 132M 120M 226M 15.18B 229M 1.59B 623M 7.93B 601M 588M 25.36B 6.81B 126M 113M 104M 94.9M 178M 11.98B 181M 1.25B 492M 6.26B 474M 464M 20.02B
Projected Income Statement - Annual - Ibnsina Pharma
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
19/10/26 EGP 10.60 0.00% 3,574,611
18/10/26 EGP 10.60 -5.94% 2,259,165
15/10/26 EGP 11.27 +1.26% 1,915,404
14/10/26 EGP 11.13 +1.18% 1,519,731
13/10/26 EGP 11.00 -2.31% 6,201,904
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Ibnsina Pharma
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.60EGP
Average target price
16.51EGP
Spread / Average Target
+55.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ibnsina Pharma
  1. Stock Market
  2. Stocks
  3. ISPH Stock